Stay updated on Amgen Press Releases

Sign up to get notified when there's something new on the Amgen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Amgen Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    A batch of items listed under Newsroom > Press Releases has been removed, including conference presentations, product/approval announcements, and financial results releases from January–April 2025. This reduces access to historical and upcoming corporate announcements on the Newsroom page.
    Difference
    21%
    Check dated 2025-12-23T07:39:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The Newsroom Press Releases page has been expanded with a longer list of 2025 releases, including items on product approvals, conference announcements, and financial results. The new entries span January through December 2025, increasing visibility of Amgen’s communications.
    Difference
    51%
    Check dated 2025-12-16T02:19:13.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Multiple press release entries have been removed from the Newsroom > Press Releases listing, including items such as the 01.08.2025 J.P. Morgan Healthcare Conference presentation, FDA approvals, and quarterly results announcements. This reduces the amount of visible press information and historical records on the page.
    Difference
    21%
    Check dated 2025-12-01T16:39:52.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new press release entry titled 'FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER' dated 11.19.2025 has been added to the Newsroom press releases page.
    Difference
    0.4%
    Check dated 2025-11-24T11:44:06.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Two new press releases were added to Amgen's Newsroom: AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS (11.04.2025) and AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL (11.08.2025). A November 2025 section header also appears on the page.
    Difference
    1%
    Check dated 2025-11-10T02:36:47.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Three new press releases were added: AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS; AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025; AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND.
    Difference
    9%
    Check dated 2025-11-03T00:54:34.000Z thumbnail image

Stay in the know with updates to Amgen Press Releases

Enter your email address, and we'll notify you when there's something new on the Amgen Press Releases page.